FDA.reportPublic FDA data

TRIACETIN

Substance profile for UNII XHX3C3X673, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.

Chemical structure for TRIACETIN
Structure render from PubChem CID 5541

Substance Identity#

UNII
XHX3C3X673
Preferred term
TRIACETIN
Registry number
102-76-1
EC number
203-051-9
Ingredient type
INGREDIENT SUBSTANCE
Molecular formula
C9H14O6
Chemical structure for TRIACETIN
Structure render from PubChem CID 5541

Chemical And Database Identifiers#

InChIKey
URAYPUMNDPQOKB-UHFFFAOYSA-N
SMILES
CC(=O)OCC(COC(C)=O)OC(C)=O
RxCUI
10756
PubChem
5541
NCIt
C82268
INN ID
836

Open Chemistry Sources#

Source, Identifier, Link table
SourceIdentifierLink
PubChem Compound5541https://pubchem.ncbi.nlm.nih.gov/compound/5541
PubChem InChIKey SearchURAYPUMNDPQOKB-UHFFFAOYSA-Nhttps://pubchem.ncbi.nlm.nih.gov/#query=URAYPUMNDPQOKB-UHFFFAOYSA-N
RxNorm10756https://mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=10756
NCI ThesaurusC82268https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C82268
FDA Substance Registration SystemXHX3C3X673https://precision.fda.gov/uniisearch/srs/unii/XHX3C3X673
European Community number203-051-9https://commonchemistry.cas.org/results?q=203-051-9

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
TRIACETININACTIVE INGREDIENTXHX3C3X673Inflamation Reduction Pack These highlights do not include all the information needed to use Inflammation Reduction Pack safely and effectively.see full prescribing information for Inflammation Reduction Pack Inflammation Reduction Pack (Inflammation Reduction Pack) KIT for use. Initial U.S. Approval:4
TRIACETININACTIVE INGREDIENTXHX3C3X673ESZOPICLONE1
TRIACETININACTIVE INGREDIENTXHX3C3X673ZOLPIDEM TARTRATE4
TRIACETININACTIVE INGREDIENTXHX3C3X673NeuroBion Tablets1
TRIACETININACTIVE INGREDIENTXHX3C3X673NeuroBion Tablets1
TRIACETININACTIVE INGREDIENTXHX3C3X673Inflamation Reduction Pack These highlights do not include all the information needed to use Inflammation Reduction Pack safely and effectively.see full prescribing information for Inflammation Reduction Pack Inflammation Reduction Pack (Inflammation Reduction Pack) KIT for use. Initial U.S. Approval:3
TRIACETININACTIVE INGREDIENTXHX3C3X67314db4981-5e50-4551-84f0-24f2c833d6291
TRIACETININACTIVE INGREDIENTXHX3C3X673SILDENAFIL1
TriacetinINACTIVE INGREDIENTXHX3C3X673L-Methyl-MC Tablets3
TRIACETININACTIVE INGREDIENTXHX3C3X673Benazepril Hydrochloride Tablets, USP, film coated for oral use1
TRIACETININACTIVE INGREDIENTXHX3C3X673DIVALPROEX SODIUM2
TRIACETININACTIVE INGREDIENTXHX3C3X673Nabumetone Tablets, USP Revised: December 2010 Rx only 1957023
TRIACETININACTIVE INGREDIENTXHX3C3X673SYNCOL1
TRIACETININACTIVE INGREDIENTXHX3C3X673These highlights do not include all the information needed to use memantine hydrochloride safely and effectively. See full prescribing information for memantine hydrochloride. MEMANTINE hydrochloride tablets, for oral use Initial U.S. Approval: 20031
TRIACETININACTIVE INGREDIENTXHX3C3X673These highlights do not include all the information needed to use galantamine hydrobromide safely and effectively. See full prescribing information for Galantamine Hydrobromide Tablets, USP. Galantamine Hydrobromide Tablets, USP for oral use Initial U.S. Approval: 20011
TRIACETININACTIVE INGREDIENTXHX3C3X673These highlights do not include all the information needed to use VIAGRA safely and effectively. See full prescribing information for VIAGRA. VIAGRA® (sildenafil citrate) tablets, for oral use Initial U.S. Approval: 19984
TRIACETININACTIVE INGREDIENTXHX3C3X673SPIRONOLACTONE TABLETS, USP3
TRIACETININACTIVE INGREDIENTXHX3C3X673Famotidine Tablets USP1
TRIACETININACTIVE INGREDIENTXHX3C3X673These highlights do not include all the information needed to use zolpidem tartrate tablets, USP safely and effectively. See full prescribing information for zolpidem tartrate tablets, USP ZOLPIDEM Tartrate Tablets, USP, for oral use CIV Initial U.S. Approval: 19921
TRIACETININACTIVE INGREDIENTXHX3C3X673These highlights do not include all the information needed to use zolpidem tartrate tablets, USP safely and effectively. See full prescribing information for zolpidem tartrate tablets, USP ZOLPIDEM Tartrate Tablets, USP, for oral use CIV Initial U.S. Approval: 19921
TRIACETININACTIVE INGREDIENTXHX3C3X673Spironolactone Tablets, USP1
TRIACETININACTIVE INGREDIENTXHX3C3X673Ondansetron Tablets,USP Rx only2
TRIACETININACTIVE INGREDIENTXHX3C3X673Ranitidine Tablets USP, 150 mg and 300 mg1
TRIACETININACTIVE INGREDIENTXHX3C3X673Spironolactone Tablets, USP2
TRIACETININACTIVE INGREDIENTXHX3C3X673Verapamil Hydrochloride Extended-Release Tablets, USP Rx Only1
TRIACETININACTIVE INGREDIENTXHX3C3X673These highlights do not include all the information needed to use LEXIVA safely and effectively. See full prescribing information for LEXIVA. LEXIVA (fosamprenavir calcium) Tablets, for oral use LEXIVA (fosamprenavir calcium) Oral Suspension Initial U.S. Approval: 20031
TRIACETININACTIVE INGREDIENTXHX3C3X673These highlights do not include all the information needed to use Divalproex Sodium Delayed Release Tablets safely and effectively. See full prescribing information for Divalproex Sodium Delayed Release Tablets. Divalproex Sodium Delayed Release Tablets USP for Oral use. Initial U.S. Approval: 19831
TRIACETININACTIVE INGREDIENTXHX3C3X673These highlights do not include all the information needed to use divalproex sodium delayed-release tablets, USP safely and effectively. See full prescribing information for divalproex sodium delayed-release tablets, USP. DIVALPROEX sodium delayed-release tablets, USP for oral use Initial U.S. Approval: 19831
TRIACETININACTIVE INGREDIENTXHX3C3X673These highlights do not include all the information needed to use clopidogrel tablets USP safely and effectively. See full prescribing information for clopidogrel tablets USP. Clopidogrel Tablets USP for oral use Initial U.S. Approval: 19971
TRIACETININACTIVE INGREDIENTXHX3C3X673Drug Facts1
TRIACETININACTIVE INGREDIENTXHX3C3X673Ibuprofen tablets USP 200mg Discount Drug Mart Drug Facts1
TRIACETININACTIVE INGREDIENTXHX3C3X673Ibuprofen tablets USP 200mg Discount Drug Mart Drug Facts1
TRIACETININACTIVE INGREDIENTXHX3C3X673Hydrocodone Polistirex and Chlorpheniramine Polistirex Extended Release Oral Suspension CII (10 mg hydrocodone bitartrate and 8 mg chlorpheniramine maleate per 5 mL) Rx only2
TRIACETININACTIVE INGREDIENTXHX3C3X673DRUG FACTS1
TRIACETININACTIVE INGREDIENTXHX3C3X673SELECT-OB ® Prenatal Supplement1
TRIACETININACTIVE INGREDIENTXHX3C3X673Falessa Kit5
TRIACETININACTIVE INGREDIENTXHX3C3X673SELECT-OB ® Chewable Caplets Prenatal Supplement1
TRIACETININACTIVE INGREDIENTXHX3C3X673These highlights do not include all the information needed to use divalproex sodium extended-release tablets USP safely and effectively. See full prescribing information for divalproex sodium extended-release tablets USP. DIVALPROEX Sodium Extended-Release Tablets USP, for Oral Use Initial U.S. Approval: 20002
TRIACETININACTIVE INGREDIENTXHX3C3X673These highlights do not include all the information needed to use clopidogrel bisulfate safely and effectively. See full prescribing information for clopidogrel tablets, USP. CLOPIDOGREL Tablets USP, for oral use Initial U.S. Approval: 19974
TRIACETININACTIVE INGREDIENTXHX3C3X6736368bb69-43e9-4304-a30d-03d593c1c05f4
TRIACETININACTIVE INGREDIENTXHX3C3X673These highlights do not include all the information needed to use CHANTIX safely and effectively. See full prescribing information for CHANTIX. CHANTIX® (varenicline) Tablets Initial U.S. Approval: 20062
TRIACETININACTIVE INGREDIENTXHX3C3X673Drug Facts1
TRIACETININACTIVE INGREDIENTXHX3C3X673Drug Facts1
TRIACETININACTIVE INGREDIENTXHX3C3X673Drug Facts1
TRIACETININACTIVE INGREDIENTXHX3C3X673Drug Facts1
TRIACETININACTIVE INGREDIENTXHX3C3X673Drug Facts1
TRIACETININACTIVE INGREDIENTXHX3C3X673Drug Facts1
TRIACETININACTIVE INGREDIENTXHX3C3X673Drug Facts1
TRIACETININACTIVE INGREDIENTXHX3C3X673Drug Facts1
TRIACETININACTIVE INGREDIENTXHX3C3X6732f4057b1-4707-4975-949e-3d62133d96f95
TRIACETININACTIVE INGREDIENTXHX3C3X673These highlights do not include all the information needed to use risperidone tablets safely and effectively. See full prescribing information for risperidone tablets. Risperidone Tablets USP, for oral use Initial U.S. Approval: 19933
TRIACETININACTIVE INGREDIENTXHX3C3X673These highlights do not include all the information needed to use INVEGA safely and effectively. See full prescribing information for INVEGA . INVEGA (paliperidone) Extended-Release Tablets Initial U.S. Approval: 2006 ® ® ®2
triacetinINACTIVE INGREDIENTXHX3C3X673BACMIN1
TRIACETININACTIVE INGREDIENTXHX3C3X673Spironolactone Tablets, USP2
TRIACETININACTIVE INGREDIENTXHX3C3X673These highlights do not include all the information needed to use zolpidem tartrate tablets safely and effectively. See full prescribing information for zolpidem tartrate tablets Zolpidem Tartrate Tablets, for oral use CIV Initial U.S. Approval: 19922
TRIACETININACTIVE INGREDIENTXHX3C3X6733859effa-7b9b-41cd-9c90-847fa99e9b342
TRIACETININACTIVE INGREDIENTXHX3C3X673These highlights do not include all the information needed to use CRESTOR safely and effectively. See full prescribing information for CRESTOR. CRESTOR (rosuvastatin calcium) tablets Initial U.S. Approval: 20032
TRIACETININACTIVE INGREDIENTXHX3C3X673Nifedipine Extended-Release Tablets, USP For Oral Use Rx Only1
TRIACETININACTIVE INGREDIENTXHX3C3X673Levetiracetam Tablets 500 mg1
TRIACETININACTIVE INGREDIENTXHX3C3X673Divalproex Sodium Delayed Release Tablets USP1
TRIACETININACTIVE INGREDIENTXHX3C3X673fb0b4228-33bd-4899-8b46-be5e9d4606d01
TRIACETININACTIVE INGREDIENTXHX3C3X673These highlights do not include all the information needed to use quetiapine fumarate tablets safely and effectively. See full prescribing information for quetiapine fumarate tablets. QUETIAPINE fumarate tablets for oral use Initial U.S. Approval: 19972
TRIACETININACTIVE INGREDIENTXHX3C3X673Ondansetron Tablets, USP1
TRIACETININACTIVE INGREDIENTXHX3C3X673Nifedipine Extended-release Tablets, USP1
TRIACETININACTIVE INGREDIENTXHX3C3X673Nifedipine Extended-Release Tablets, USP4
TRIACETININACTIVE INGREDIENTXHX3C3X673Nabumetone Tablets, USP Revised: December 2010 Rx only 1957021
TRIACETININACTIVE INGREDIENTXHX3C3X673Losartan Potassium and Hydrochlorothiazide Tablets USP1
TRIACETININACTIVE INGREDIENTXHX3C3X673Famotidine Tablets USP1
TRIACETININACTIVE INGREDIENTXHX3C3X673FENOFIBRATE TABLETS, 54 mg and 160 mg1
TRIACETININACTIVE INGREDIENTXHX3C3X673HYDROXYZINE HYDROCHLORIDE TABLETS, USP1
TRIACETININACTIVE INGREDIENTXHX3C3X673Metoprolol Tablets, USP Rx Only2
TRIACETININACTIVE INGREDIENTXHX3C3X673Paroxetine Tablets, USP Rx only2
TRIACETININACTIVE INGREDIENTXHX3C3X673These highlights do not include all the information needed to use divalproex sodium delayed-release tablets, USP safely and effectively. See full prescribing information for divalproex sodium delayed-release tablets, USP . D ivalproex Sodium Delayed-Release Tablets, USP for Oral Use Initial U.S. Approval: 19831
TRIACETININACTIVE INGREDIENTXHX3C3X673DIVALPROEX SODIUM DELAYED-RELEASE TABLETS1
TRIACETININACTIVE INGREDIENTXHX3C3X673These highlights do not include all the information needed to use clopidogrel bisulfate safely and effectively. See full prescribing information for clopidogrel tablets, USP. CLOPIDOGREL Tablets USP, for oral use Initial U.S. Approval: 19971
TRIACETININACTIVE INGREDIENTXHX3C3X673PROPAFENONE HYDROCHLORIDE TABLETS2
triacetinINACTIVE INGREDIENTXHX3C3X673Famotidine Tablets USP2
TRIACETININACTIVE INGREDIENTXHX3C3X673Acetaminophen, Caffeine, Diuretic, Pyrilamine Maleate, Antihistamine1
TRIACETININACTIVE INGREDIENTXHX3C3X673These highlights do not include all the information needed to use risperidone tablets safely and effectively. See full prescribing information for risperidone tablets. Risperidone Tablets USP, for oral use Initial U.S. Approval: 19931
TRIACETININACTIVE INGREDIENTXHX3C3X673These highlights do not include all the information needed to use tamsulosin hydrochloride capsules safely and effectively. See full prescribing information for tamsulosin hydrochloride capsules. Initial U.S. Approval: 19971
TRIACETININACTIVE INGREDIENTXHX3C3X673dc9f4282-1cd8-4f67-9dfc-ad627453256c1
TRIACETININACTIVE INGREDIENTXHX3C3X673Nifedipine Extended-release Tablets, USP1
TRIACETININACTIVE INGREDIENTXHX3C3X673These highlights do not include all the information needed to use divalproex sodium delayed-release tablets, USP safely and effectively. See full prescribing information for divalproex sodium delayed-release tablets, USP . D ivalproex Sodium Delayed-Release Tablets, USP for Oral Use Initial U.S. Approval: 19831
TRIACETININACTIVE INGREDIENTXHX3C3X673These highlights do not include all the information needed to use divalproex sodium extended-release tablets safely and effectively. See full prescribing information for divalproex sodium extended-release tablets. Divalproex Sodium Extended-release Tablets, USP for oral use Initial U.S. Approval: 20001
TRIACETININACTIVE INGREDIENTXHX3C3X673These highlights do not include all the information needed to use clopidogrel bisulfate safely and effectively. See full prescribing information for clopidogrel tablets, USP. Clopidogrel Tablets, USP Initial U.S. Approval: 19971
TRIACETININACTIVE INGREDIENTXHX3C3X673These highlights do not include all the information needed to use clopidogrel safely and effectively. See full prescribing information for clopidogrel tablets. Clopidogrel Tablets, USP Initial U.S. Approval: 19971
TRIACETININACTIVE INGREDIENTXHX3C3X673Nifedipine Extended-release Tablets, USP1
TRIACETININACTIVE INGREDIENTXHX3C3X673ZOLPIDEM TARTRATE, TABLETS CIV1
triacetinINACTIVE INGREDIENTXHX3C3X673These highlights do not include all the information needed to use Venlafaxine Extended Release Tablets safely and effectively. See full prescribing information for Venlafaxine Extended Release Tablets. Venlafaxine Extended Release Tablets (venlafaxine hydrochloride) Extended Release Tablets for Oral use Initial U.S. Approval: 19932
TRIACETININACTIVE INGREDIENTXHX3C3X673Unknown Title1
TRIACETININACTIVE INGREDIENTXHX3C3X673healthy mama PRENATAL VITAMINS2
TRIACETININACTIVE INGREDIENTXHX3C3X673These highlights do not include all the information needed to use zolpidem tartrate tablets safely and effectively. See full prescribing information for zolpidem tartrate tablets Zolpidem Tartrate Tablets, for oral use CIV Initial U.S. Approval: 19921
TRIACETININACTIVE INGREDIENTXHX3C3X673One Daily Multi Vitamin Dietary Supplement1
TRIACETININACTIVE INGREDIENTXHX3C3X673BC11265
TRIACETININACTIVE INGREDIENTXHX3C3X673HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use Amoxicillin and Clavulanate Potassium Tablets USP, Amoxicillin and Clavulanate Potassium for Oral Suspension USP, and Amoxicillin and Clavulanate Potassium Tablets USP (Chewable) safely and effectively. See full prescribing information for Amoxicillin and Clavulanate Potassium Tablets USP, Amoxicillin and Clavulanate Potassium for Oral Suspension USP, and Amoxicillin and Clavulanate Potassium Tablets USP1
TRIACETININACTIVE INGREDIENTXHX3C3X673Prenatal Plus Vitamin and Mineral Tablet Multi-Vitamin Rx Only2
TRIACETININACTIVE INGREDIENTXHX3C3X673Prenatal Plus Vitamin and Mineral Tablet Multi-Vitamin Rx Only2
TRIACETININACTIVE INGREDIENTXHX3C3X673These highlights do not include all the information needed to use simvastatin tablets USP safely and effectively. See full prescribing information for simvastatin tablets USP. SIMVASTATIN tablets USP for oral use Initial U.S. Approval: 19911
triacetinINACTIVE INGREDIENTXHX3C3X673These highlights do not include all the information needed to use COMPLERA safely and effectively. See full prescribing information for COMPLERA. COMPLERA ® (emtricitabine/rilpivirine/tenofovir disoproxil fumarate) tablets, for oral use Initial U.S. Approval: 20111
TRIACETININACTIVE INGREDIENTXHX3C3X673CIPROFLOXACIN TABLETS USP Rx only1
triacetinINACTIVE INGREDIENTXHX3C3X673These highlights do not include all the information needed to use TRUVADA safely and effectively. See full prescribing information for TRUVADA. TRUVADA ® (emtricitabine/tenofovir disoproxil fumarate) tablets, for oral use Initial U.S. Approval: 20042
TRIACETININACTIVE INGREDIENTXHX3C3X673Azithromycin Tablets USP, 250 mg and 500 mg 7146 7169 Rx only1
TRIACETININACTIVE INGREDIENTXHX3C3X673These highlights do not include all the information needed to use EXALGO ® safely and effectively. See full prescribing information for EXALGO. EXALGO (hydromorphone HCl) Extended-Release Tablets, for oral use, CII Initial U.S. Approval: 19841
TRIACETININACTIVE INGREDIENTXHX3C3X673a147850e-f881-4f9b-bf37-1b9e8cdf40202
TRIACETININACTIVE INGREDIENTXHX3C3X673Genuine First Aid - FIRST AID KIT Essentials 33 Pieces3
TRIACETININACTIVE INGREDIENTXHX3C3X673Ready America First Aid Outdoor Kit 107 pcs2
TRIACETININACTIVE INGREDIENTXHX3C3X673THRULIFE EXTRA STRENGTH HEADACHE RELIEF4
TRIACETININACTIVE INGREDIENTXHX3C3X673Good Neighbor Senna Laxative6
TRIACETININACTIVE INGREDIENTXHX3C3X673e026e1c6-19d0-4870-b277-74124a1d4a441
TRIACETININACTIVE INGREDIENTXHX3C3X673These highlights do not include all the information needed to use clopidogrel safely and effectively. See full prescribing information for clopidogrel. Clopidogrel Tablets, USP Initial U.S. Approval: 19972
TRIACETININACTIVE INGREDIENTXHX3C3X673Entacapone Tablets, USP*2
TRIACETININACTIVE INGREDIENTXHX3C3X673METFORMIN 500 SUN1
TRIACETININACTIVE INGREDIENTXHX3C3X673METFORMIN CARACO1
TRIACETININACTIVE INGREDIENTXHX3C3X673Sennosides 8.6 mg2
TRIACETININACTIVE INGREDIENTXHX3C3X673Sumatriptan Succinate2
TRIACETININACTIVE INGREDIENTXHX3C3X673DRUG FACTS2
TRIACETININACTIVE INGREDIENTXHX3C3X673DRUG FACTS2
TRIACETININACTIVE INGREDIENTXHX3C3X673IMITREX ® ( sumatriptan succinate ) Tablets4
TriacetinINACTIVE INGREDIENTXHX3C3X673These highlights do not include all the information needed to use CIALIS safely and effectively. See full prescribing information for CIALIS. CIALIS (tadalafil) tablets, for oral use Initial U.S. Approval: 20032
TRIACETININACTIVE INGREDIENTXHX3C3X673c80870d1-b42f-4478-9844-7eebf99d43a34